Announcements Trials
Browse Landscape Eligibility

Clinical Trials

9 trials
RecentStart dateEnrollment
GIST × Clear all

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 4Unknown 2Recruiting 1Not yet recruiting 1Approved for marketing 1

Sponsor Class

OTHER 4INDUSTRY 3NIH 1NETWORK 1

Study Type

Interventional 5Observational 3Expanded_access 1

Sponsor

Cancer Type

Sarcoma 9

Conditions

Breast Neoplasms 10998Neoplasms 8807Carcinoma, Non-Small-Cell Lung 5711Prostatic Neoplasms 5278Colorectal Neoplasms 4951Lung Neoplasms 4210Pancreatic Neoplasms 3003Multiple Myeloma 3001Neoplasm Metastasis 2954Leukemia, Myeloid, Acute 2927Carcinoma, Hepatocellular 2734Ovarian Neoplasms 2657Melanoma 2635Stomach Neoplasms 2567Lymphoma 2502Head and Neck Neoplasms 2162Recurrence 2132Precursor Cell Lymphoblastic Leukemia-Lymphoma 2069Leukemia 1992Brain Neoplasms 1971Colonic Neoplasms 1939Lymphoma, Non-Hodgkin 1894Rectal Neoplasms 1846Uterine Cervical Neoplasms 1806Glioblastoma 1699Leukemia, Lymphocytic, Chronic, B-Cell 1663Carcinoma, Renal Cell 1597Squamous Cell Carcinoma of Head and Neck 1550Lymphoma, Follicular 1526Esophageal Neoplasms 1516

Interventions

vandetanib 1pazopanib 1olverembatinib 1lenvatinib 1avapritinib 1Surgical Procedures, Operative 1Imatinib Mesylate 1Coal Tar 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT07096609 2025-07-31

LONGIST

Asan Medical Center

Phase 1/2 Not yet recruiting
48 enrolled
Sarcoma

GIST

NCT06640361 2024-12-27

A Study of Olverembatinib in SDH-deficient GIST.

Ascentage Pharma Group Inc.

Phase 3 Recruiting
40 enrolled
Sarcoma

GIST

NCT04599660 2024-02-01

RetroGIST

Italian Sarcoma Group

Completed
700 enrolled
Sarcoma

GIST

NCT05895942 2023-06-09

EMMBKM

Xijing Hospital

Unknown
190 enrolled
Sarcoma

GIST

NCT03862885 2020-07-27

Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST

Blueprint Medicines Corporation

Approved for marketing
Sarcoma

GIST

NCT02015065 2020-03-30

Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled 14 charts
Sarcoma

GIST

NCT03082079 2017-05-16

Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)

Nanfang Hospital, Southern Medical University

Phase NA Unknown
90 enrolled
Sarcoma

GIST

NCT01323400 2016-02-25

PAZOGIST

Centre Leon Berard

Phase 2 Completed
81 enrolled
Sarcoma

GIST

NCT01459757 2013-06-19

Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib

Pfizer

Completed
322 enrolled
Sarcoma

GIST

Data powered by HemOnc (CC BY 4.0) Colophon âš¡